MPR Weekly Dose Podcast Episode 51

<p><span style="font-weight: 400;">This week we cover AstraZeneca and the swift decision to restart their COVID-19 vaccine candidate trial; Pfizer and BioNTech want to expand enrollment for their</span><em><span style= "font-weight: 400;"> </span></em><span style= "font-weight: 400;">candidate vaccine trial; There’s the janus kinase inhibitor that could help reduce recovery time; An investigative antiviral may ease strain on hospitalizations;</span> Aortic aneurysm, dissection assessed with fluoroquinolones; and a retrospective study compared cardiac events with azithromycin and amoxicillin use.</p>